Silexion Therapeutics Corp (SLXN) stock: key figures, P/E, revenue and dividend
Health Care · Israel
Silexion Therapeutics Corp financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -11.63 m USD |
| EBIT | -11.91 m USD |
| Net income | -11.91 m USD |
| Diluted EPS – continuing operations | 8.96 USD |
Full history since 2022, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Silexion Therapeutics Corp
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
More stocks
- BIOTRICITY INC. (BTCY)
- BMP AI Technologies, Inc. (BMPA)
- QUEST PATENT RESEARCH CORP (QPRC)
- Arcadia Biosciences, Inc. (RKDA)
- LogicMark, Inc. (LGMK)
- CLOUDASTRUCTURE, INC. (CSAI)
- Nuvve Holding Corp. (NVVE)
- Appsoft Technologies, Inc. (ASFT)
- GeoVax Labs, Inc. (GOVX)
- JRSIS HEALTH CARE Corp (JRSS)
- POWERCOMPUTE, INC. (PWCM)
- Vocodia Holdings Corp (VHAI)
Not investment advice. All data without warranty, price as of 16.11.2026. Details in the risk notice.